Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorNICOLO, C.
dc.contributor.authorPERIER, C.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorPRAGUE, Melanie
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorBELLERA, Carine
dc.contributor.authorMACGROGAN, G.
dc.contributor.authorSAUT, O.
dc.contributor.authorBENZEKRY, S.
dc.date.accessioned2021-02-08T15:21:34Z
dc.date.available2021-02-08T15:21:34Z
dc.date.issued2020
dc.identifier.issn2473-4276 (Electronic) 2473-4276 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/26182
dc.description.abstractEnPURPOSE For patients with early-stage breast cancer, predicting the risk of metastatic relapse is of crucial importance. Existing predictive models rely on agnostic survival analysis statistical tools (eg, Cox regression). Here we define and evaluate the predictive ability of a mechanistic model for time to distant metastatic relapse. METHODS The data we used for our model consisted of 642 patients with 21 clinicopathologic variables. A mechanistic model was developed on the basis of two intrinsic mechanisms of metastatic progression: growth (parameter α) and dissemination (parameter μ). Population statistical distributions of the parameters were inferred using mixed-effects modeling. A random survival forest analysis was used to select a minimal set of five covariates with the best predictive power. These were further considered to individually predict the model parameters by using a backward selection approach. Predictive performances were compared with classic Cox regression and machine learning algorithms. RESULTS The mechanistic model was able to accurately fit the data. Covariate analysis revealed statistically significant association of Ki67 expression with α (P = .001) and EGFR expression with μ (P = .009). The model achieved a c-index of 0.65 (95% CI, 0.60 to 0.71) in cross-validation and had predictive performance similar to that of random survival forest (95% CI, 0.66 to 0.69) and Cox regression (95% CI, 0.62 to 0.67) as well as machine learning classification algorithms. CONCLUSION By providing informative estimates of the invisible metastatic burden at the time of diagnosis and forward simulations of metastatic growth, the proposed model could be used as a personalized prediction tool for routine management of patients with breast cancer.
dc.language.isoENen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectEPICENE
dc.subjectSISTM
dc.title.enMachine Learning and Mechanistic Modeling for Prediction of Metastatic Relapse in Early-Stage Breast Cancer
dc.title.alternativeJCO Clin Cancer Informen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1200/cci.19.00133en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed32213092en_US
bordeaux.journalJCO Clinical Cancer Informaticsen_US
bordeaux.page259-274en_US
bordeaux.volume4en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamSISTM_BPH
bordeaux.teamEPICENE_BPH
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.exportfalse
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=JCO%20Clinical%20Cancer%20Informatics&rft.date=2020&rft.volume=4&rft.spage=259-274&rft.epage=259-274&rft.eissn=2473-4276%20(Electronic)%202473-4276%20(Linking)&rft.issn=2473-4276%20(Electronic)%202473-4276%20(Linking)&rft.au=NICOLO,%20C.&PERIER,%20C.&PRAGUE,%20Melanie&BELLERA,%20Carine&MACGROGAN,%20G.&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée